Tags : Lyra SARS-CoV-2 Assay

Quidel’s Lyra SARS-CoV-2 Assay Receives the US FDA’s Expanded Emergency

Tuba Khan March 27, 2020

Shots: Quidel’s Lyra SARS-CoV-2 Assay has received expanded FDA’s EUA to allow testing with three additional thermocyclers: Applied Biosystems 7500 Standard, Roche LightCycler 480, and Qiagen Rotor-Gene Q Under the […]readmore

Tags : Lyra SARS-CoV-2 Assay

Quidel’s Lyra SARS-CoV-2 Assay Receives the US FDA’s Expanded Emergency

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Lyra SARS-CoV-2 Assay

Quidel’s Lyra SARS-CoV-2 Assay Receives the US FDA’s Expanded Emergency

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company